| Name | Maftivimab |
|---|
| Description | Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and Drug Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |